PHR 📈 Phreesia - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US71944F1066

PHR: Scheduling, Registration, Payment, Referral, Insurance, Reminders

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware. Web URL: https://www.phreesia.com

Additional Sources for PHR Stock

PHR Stock Overview

Market Cap in USD 1,490m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2019-07-18

PHR Stock Ratings

Growth 5y -23.9%
Fundamental -37.7%
Dividend -
Rel. Strength Industry -129
Analysts 4.53/5
Fair Price Momentum 22.31 USD
Fair Price DCF -

PHR Dividends

No Dividends Paid

PHR Growth Ratios

Growth Correlation 3m 17%
Growth Correlation 12m -41.2%
Growth Correlation 5y -52.7%
CAGR 5y -0.76%
CAGR/Mean DD 5y -0.02
Sharpe Ratio 12m 0.38
Alpha -21.61
Beta 1.32
Volatility 59.58%
Current Volume 749.3k
Average Volume 20d 480.1k
What is the price of PHR stocks?
As of December 22, 2024, the stock is trading at USD 25.16 with a total of 749,260 shares traded.
Over the past week, the price has changed by -2.89%, over one month by +28.52%, over three months by +0.34% and over the past year by -0.67%.
Is Phreesia a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Phreesia (NYSE:PHR) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.71 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHR as of December 2024 is 22.31. This means that PHR is currently overvalued and has a potential downside of -11.33%.
Is PHR a buy, sell or hold?
Phreesia has received a consensus analysts rating of 4.53. Therefor, it is recommend to buy PHR.
  • Strong Buy: 9
  • Buy: 5
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PHR stock price target?
According to ValueRays Forecast Model, PHR Phreesia will be worth about 25.1 in December 2025. The stock is currently trading at 25.16. This means that the stock has a potential downside of -0.36%.
Issuer Forecast Upside
Wallstreet Target Price 30.2 20.1%
Analysts Target Price 36.1 43.4%
ValueRay Target Price 25.1 -0.4%